VF
CCCC icon

Virtu Financial’s C4 Therapeutics CCCC Stock Holding History

Virtu Financial’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
+98,094
New +$336K 0.01% 567
2026
Q1 		– Sell
-20,655
Closed -$39K – 1697
2025
Q4 		$39K Buy
+20,655
New +$48.9K ﹤0.01% 1332
2025
Q3 		– Sell
-24,377
Closed -$35K – 1518
2025
Q2 		$35K Buy
+24,377
New +$35.5K ﹤0.01% 1184

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virtu Financial's CCCC Position: Q2 2026 in Review

Virtu Financial opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 98,094 shares worth $458K. The stake represents 0.01% of the portfolio and ranks #567 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CCCC as recently as Q4 2025.

Virtu Financial first reported a position in CCCC in Q2 2025 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Virtu Financial held 98,094 shares of C4 Therapeutics worth $458K as of Q2 2026.
  • C4 Therapeutics was a new Virtu Financial position in Q2 2026.
  • C4 Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #567 holding.
  • Virtu Financial first reported a position in C4 Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.